What is the share price of Entero Healthcare Solutions Ltd (ENTERO) today?
The share price of ENTERO as on 5th December 2025 is ₹1033.80. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Entero Healthcare Solutions Ltd (ENTERO) share?
The past returns of Entero Healthcare Solutions Ltd (ENTERO) share are- Past 1 week: 0.52%
- Past 1 month: -3.42%
- Past 3 months: -14.09%
- Past 6 months: -15.39%
- Past 1 year: -27.47%
- Past 3 years: N/A%
- Past 5 years: -10.07%
What are the peers or stocks similar to Entero Healthcare Solutions Ltd (ENTERO)?
The peers or stocks similar to Entero Healthcare Solutions Ltd (ENTERO) include:What is the market cap of Entero Healthcare Solutions Ltd (ENTERO) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Entero Healthcare Solutions Ltd (ENTERO) is ₹4498.16 Cr as of 5th December 2025.What is the 52 week high and low of Entero Healthcare Solutions Ltd (ENTERO) share?
The 52-week high of Entero Healthcare Solutions Ltd (ENTERO) is ₹1563.90 and the 52-week low is ₹1022.What is the PE and PB ratio of Entero Healthcare Solutions Ltd (ENTERO) stock?
The P/E (price-to-earnings) ratio of Entero Healthcare Solutions Ltd (ENTERO) is 47.44. The P/B (price-to-book) ratio is 2.54.Which sector does Entero Healthcare Solutions Ltd (ENTERO) belong to?
Entero Healthcare Solutions Ltd (ENTERO) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Entero Healthcare Solutions Ltd (ENTERO) shares?
You can directly buy Entero Healthcare Solutions Ltd (ENTERO) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Entero Healthcare Solutions Ltd
ENTERO Share Price
1,033.800.52% (-5.40)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
ENTERO Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
ENTERO Performance & Key Metrics
ENTERO Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 40.70 | 2.54 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.87 | 5.82 | 0.59% |
75%
Analysts have suggested that investors can buy this stock
from 4 analysts
Price Upside
Earnings Growth
Rev. Growth
ENTERO Company Profile
Entero Healthcare Solutions is an India-based technology-driven and integrated healthcare products distribution company.
SUNPHARMA
PE Ratio
39.63
39.63
1Y Return
0.45%
0.45%
Buy Reco %
91.67
91.67
TORNTPHARM
PE Ratio
67.04
67.04
1Y Return
12.63%
12.63%
Buy Reco %
76.92
76.92
CIPLA
PE Ratio
23.30
23.30
1Y Return
1.51%
1.51%
Buy Reco %
70.00
70.00
DRREDDY
PE Ratio
18.77
18.77
1Y Return
2.85%
2.85%
Buy Reco %
41.94
41.94
LUPIN
PE Ratio
29.21
29.21
1Y Return
1.24%
1.24%
Buy Reco %
72.22
72.22
ENTERO Sentiment Analysis
ENTERO Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
ENTERO Stock Summary · November 2025
The company demonstrated robust financial performance in Q2 FY26, achieving a 20.8% year-on-year revenue increase, driven by strategic acquisitions in the high-growth MedTech sector. Despite facing challenges from recent GST changes and delays in closing new deals, management remains optimistic about future growth, particularly in the second half of the fiscal year, where they anticipate improved margins and cash flow. Significant investments in technology and operational efficiency are expected to enhance customer engagement and streamline inventory management. As the company focuses on integrating acquisitions and expanding its product portfolio, it aims to capture greater market share and achieve its ambitious revenue targets, reflecting a positive market sentiment towards its growth trajectory.
ENTERO Stock Growth Drivers
ENTERO Stock Growth Drivers
6Strong Financial Performance
Entero Healthcare Solutions reported a robust financial performance in Q2 FY26, with revenue reaching INR
Successful Acquisitions and Growth in MedTech
The company made significant strides in the MedTech segment, completing five acquisitions between July and
ENTERO Stock Challenges
ENTERO Stock Challenges
4Revenue Growth Shortfall
The company has reported a 20% growth in revenue for the current year, which is
Increased Expenses and Interest Costs
There has been a notable increase in interest costs due to the utilization of funds
ENTERO Forecast
ENTERO Forecasts
Price
Revenue
Earnings
ENTERO Share Price Forecast
ENTERO Share Price Forecast
2025
Current
₹1,033.80
Baseline
Forecast for Dec 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹1,033.80
Baseline
Forecast for Dec 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
ENTERO Company Revenue Forecast
ENTERO Company Revenue Forecast
2025
Current
₹5.14
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
2025
Current
₹5.14
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
ENTERO Stock EPS (Earnings Per Share) Forecast
ENTERO Stock EPS (Earnings Per Share) Forecast
2025
Current
₹21.80
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹21.80
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
ENTERO
ENTERO
Income
Balance Sheet
Cash Flow
Annual Normal View
ENTERO Income Statement
ENTERO Income Statement
Annual Normal View
| Financial Year | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,354.28 | 1,783.66 | 2,526.55 | 3,305.72 | 3,936.72 | 5,135.29 | 5,698.22 | |||||||
Raw Materials | 1,277.54 | 1,686.57 | 2,342.47 | 3,051.26 | 3,627.81 | 4,756.49 | 5,461.75 | |||||||
| Power & Fuel Cost | 2.17 | 3.39 | 4.07 | 4.25 | 5.60 | 7.20 | ||||||||
| Employee Cost | 56.13 | 74.94 | 114.81 | 128.14 | 151.15 | 199.04 | ||||||||
| Selling & Administrative Expenses | 23.60 | 32.53 | 33.75 | 55.19 | 66.96 | 87.40 | ||||||||
| Operating & Other expenses | -33.29 | -39.24 | 2.53 | -2.64 | -41.06 | -125.89 | ||||||||
EBITDA | 28.13 | 25.47 | 28.92 | 69.52 | 126.26 | 211.05 | 236.47 | |||||||
| Depreciation/Amortization | 11.50 | 16.28 | 19.75 | 24.24 | 25.02 | 30.69 | 35.29 | |||||||
| PBIT | 16.63 | 9.19 | 9.17 | 45.28 | 101.24 | 180.36 | 201.18 | |||||||
| Interest & Other Items | 12.77 | 20.04 | 28.98 | 48.97 | 65.68 | 41.62 | 43.52 | |||||||
| PBT | 3.86 | -10.85 | -19.81 | -3.69 | 35.56 | 138.74 | 157.66 | |||||||
| Taxes & Other Items | 2.92 | 4.69 | 10.10 | 7.87 | -3.55 | 43.92 | 47.13 | |||||||
| Net Income | 0.94 | -15.54 | -29.91 | -11.56 | 39.11 | 94.82 | 110.53 | |||||||
| EPS | 93.81 | -1,550.90 | -151.44 | -29.04 | 16.43 | 21.80 | 25.41 | |||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ENTERO Company Updates
FY 2026FY 2026
Investor Presentation
Nov 12PDF
Aug 8PDF
ENTERO Stock Peers
ENTERO Past Performance & Peer Comparison
ENTERO Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Entero Healthcare Solutions Ltd | 47.44 | 2.54 | — |
| Sun Pharmaceutical Industries Ltd | 39.63 | 5.98 | 0.89% |
| Torrent Pharmaceuticals Ltd | 67.04 | 16.88 | 0.85% |
| Cipla Ltd | 23.30 | 3.93 | 1.05% |
ENTERO Stock Price Comparison
Compare ENTERO with any stock or ETFCompare ENTERO with any stock or ETF
ENTERO
ENTERO Holdings
ENTERO Shareholdings
ENTERO Promoter Holdings Trend
ENTERO Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
ENTERO Institutional Holdings Trend
ENTERO Institutional Holdings Trend
Increased Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has increased by 1.93%
Decreased Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has decreased by 2.53%
ENTERO Shareholding Pattern
ENTERO Shareholding Pattern
ENTERO Shareholding History
ENTERO Shareholding History
Foreign Institutions
Mutual Funds Invested in ENTERO
Mutual Funds Invested in ENTERO
No mutual funds holding trends are available
Top 5 Mutual Funds holding Entero Healthcare Solutions Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 0.2493% | Percentage of the fund’s portfolio invested in the stock 0.63% | Change in the portfolio weight of the stock over the last 3 months -0.17% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 51/64 (-7) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.1374% | Percentage of the fund’s portfolio invested in the stock 0.23% | Change in the portfolio weight of the stock over the last 3 months -0.04% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 215/295 (-3) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0006% | Percentage of the fund’s portfolio invested in the stock 0.01% | Change in the portfolio weight of the stock over the last 3 months -0.00% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 745/795 (-9) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing ENTERO stock
smallcases containing ENTERO stock
Looks like this stock is not in any smallcase yet.
ENTERO Events
ENTERO Events
ENTERO Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
ENTERO has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
ENTERO Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
ENTERO has not given any dividends in last 5 years
ENTERO Dividends
ENTERO Dividends
Hmm, looks like data is unavailable here. Please come back after some timeENTERO Stock News & Opinions
ENTERO Stock News & Opinions
Articles & Videos
Earnings
Entero Healthcare Solutions consolidated net profit rises 33.78% in the September 2025 quarter
Net profit of Entero Healthcare Solutions rose 33.78% to Rs 31.60 crore in the quarter ended September 2025 as against Rs 23.62 crore during the previous quarter ended September 2024. Sales rose 20.78% to Rs 1570.95 crore in the quarter ended September 2025 as against Rs 1300.69 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales1570.951300.69 21 OPM %3.953.26 - PBDT54.4642.27 29 PBT44.6334.78 28 NP31.6023.62 34 Powered by Capital Market - Live
3 weeks agoCapital Market - Live
Earnings
Entero Healthcare Solutions standalone net profit declines 62.82% in the September 2025 quarter
Net profit of Entero Healthcare Solutions declined 62.82% to Rs 5.70 crore in the quarter ended September 2025 as against Rs 15.33 crore during the previous quarter ended September 2024. Sales declined 26.24% to Rs 83.22 crore in the quarter ended September 2025 as against Rs 112.83 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales83.22112.83 -26 OPM %-15.13-5.38 - PBDT10.9322.35 -51 PBT7.6120.22 -62 NP5.7015.33 -63 Powered by Capital Market - Live
3 weeks agoCapital Market - Live
Corporate
Entero Healthcare Solutions to convene board meeting
Entero Healthcare Solutions will hold a meeting of the Board of Directors of the Company on 12 November 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Entero Healthcare Solutions consolidated net profit rises 38.45% in the June 2025 quarter
Net profit of Entero Healthcare Solutions rose 38.45% to Rs 27.80 crore in the quarter ended June 2025 as against Rs 20.08 crore during the previous quarter ended June 2024. Sales rose 27.96% to Rs 1403.82 crore in the quarter ended June 2025 as against Rs 1097.04 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales1403.821097.04 28 OPM %3.572.75 - PBDT45.2333.91 33 PBT36.3627.30 33 NP27.8020.08 38 Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Entero Healthcare Solutions to discuss results
Entero Healthcare Solutions will hold a meeting of the Board of Directors of the Company on 8 August 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Entero Healthcare Solutions to convene AGM
Entero Healthcare Solutions announced that the 7th Annual General Meeting(AGM) of the company will be held on 18 September 2025.Powered by Capital Market - Live
5 months agoCapital Market - Live
Earnings
Entero Healthcare Solutions consolidated net profit rises 22.51% in the March 2025 quarter
Net profit of Entero Healthcare Solutions rose 22.51% to Rs 25.69 crore in the quarter ended March 2025 as against Rs 20.97 crore during the previous quarter ended March 2024. Sales rose 29.48% to Rs 1339.06 crore in the quarter ended March 2025 as against Rs 1034.18 crore during the previous quarter ended March 2024. For the full year,net profit rose 142.44% to Rs 94.82 crore in the year ended March 2025 as against Rs 39.11 crore during the previous year ended March 2024. Sales rose 29.92% to Rs 5095.78 crore in the year ended March 2025 as against Rs 3922.31 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales1339.061034.18 29 5095.783922.31 30 OPM %3.652.79 -3.372.85 - PBDT45.7220.70 121 169.4360.57 180 PBT37.2313.56 175 138.7435.56 290 NP25.6920.97 23 94.8239.11 142 Powered by Capital Market - Live
6 months agoCapital Market - Live
Spotlight
Entero Healthcare Solutions Ltd leads losers in 'B' group
Oriental Aromatics Ltd, Ravikumar Distilleries Ltd, Capital India Finance Ltd and RACL Geartech Ltd are among the other losers in the BSE's 'B' group today, 28 May 2025.Entero Healthcare Solutions Ltd tumbled 10.98% to Rs 1304.3 at 14:32 IST.The stock was the biggest loser in the BSE's 'B' group.On the BSE, 20732 shares were traded on the counter so far as against the average daily volumes of 2645 shares in the past one month.Oriental Aromatics Ltd lost 10.94% to Rs 380.85. The stock was the second biggest loser in 'B' group.On the BSE, 45902 shares were traded on the counter so far as against the average daily volumes of 7756 shares in the past one month.Ravikumar Distilleries Ltd crashed 9.95% to Rs 29.7. The stock was the third biggest loser in 'B' group.On the BSE, 28042 shares were traded on the counter so far as against the average daily volumes of 4477 shares in the past one month.Capital India Finance Ltd corrected 9.83% to Rs 34.77. The stock was the fourth biggest loser in 'B' group.On the BSE, 1.99 lakh shares were traded on the counter so far as against the average daily volumes of 42280 shares in the past one month.RACL Geartech Ltd pared 7.96% to Rs 1010.1. The stock was the fifth biggest loser in 'B' group.On the BSE, 5799 shares were traded on the counter so far as against the average daily volumes of 2463 shares in the past one month.Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Entero Healthcare Solutions announces board meeting date
Entero Healthcare Solutions will hold a meeting of the Board of Directors of the Company on 27 May 2025.Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Entero Healthcare Solutions director resigns
Entero Healthcare Solutions announced the resignation of Vipul Indravadan Desai, as a representative of Prasid Uno Family Trust, as Non-Executive Non Independent Director from the Directorship of the Company w.e.f 29 May 2025. Powered by Capital Market - Live
6 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 30.55%, vs industry avg of 10.04%
Over the last 5 years, market share increased from 0.54% to 1.22%
Over the last 5 years, net income has grown at a yearly rate of 151.63%, vs industry avg of 20.02%